Steven Coca

Search results

• Weekly: ProKidney Class A (PROK: $1.66) lifts 2.5% on weak volume; +4c [2.5%]

  Coca, S.

  18/01/25

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.62) shares post worst week in three weeks; -11c [6.4%]

  Coca, S.

  11/01/25

  1 item of Media coverage

  Press/Media

• ProKidney Class A decreases 1.8% in 2025

  Coca, S.

  10/01/25

  1 item of Media coverage

  Press/Media

• ProKidney Class A dips 1% in past year

  Coca, S.

  6/01/25

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.85) jumps 9% on thin volume; +15c [8.8%]

  Coca, S.

  4/01/25

  1 item of Media coverage

  Press/Media

• Monthly: ProKidney Class A (PROK: $1.69) drops 15% on high volatility in December 2024

  Coca, S.

  2/01/25

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.70) surges 13% on weak volume; +19c [12.6%]

  Coca, S.

  28/12/24

  1 item of Media coverage

  Press/Media

• Findings in Male Kidney Diseases and Conditions Reported from Johns Hopkins University School of Medicine (Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors)

  Coca, S. & Himmelfarb, J.

  26/12/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.51) down 27% in 2 weeks; -56c [-27.1%]

  Coca, S.

  23/12/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.51) down 27% in 2 weeks; -28c [15.6%]

  Coca, S.

  21/12/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.79) plunges 14% - trailing 83% of stocks; -28c [13.5%]

  Coca, S.

  14/12/24

  1 item of Media coverage

  Press/Media

• ProKidney Class A increases 5.6% in 2024

  Coca, S.

  13/12/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $2.07) lifts 3.5% on low volume; +7c [3.5%]

  Coca, S.

  7/12/24

  1 item of Media coverage

  Press/Media

• ProKidney Class A strengthens 8% in past year

  Coca, S.

  3/12/24

  1 item of Media coverage

  Press/Media

• Monthly: ProKidney Class A (PROK: $2.0) rises 25% on high volatility in November 2024

  Coca, S.

  2/12/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.69) down 16% in 2 weeks; -0.5c [0.3%]

  Coca, S.

  23/11/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.70) plummets 15% on weak volume; -30.5c [15.2%]

  Coca, S.

  16/11/24

  1 item of Media coverage

  Press/Media

• Past Week: ProKidney Class A (PROK: $1.90) in top 1% performers of NASDAQ market in past week; +30c [18.8%]

  Coca, S.

  11/11/24

  3 items of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $2.0) in top 1% performers of NASDAQ market in past week; +45c [29.0%]

  Coca, S.

  9/11/24

  1 item of Media coverage

  Press/Media

• ProKidney Class A climbs 8.4% in 2024

  Coca, S.

  8/11/24

  1 item of Media coverage

  Press/Media

• Data on Marijuana/Cannabis Reported by Researchers at Icahn School of Medicine at Mount Sinai (A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption On Long-term Kidney Outcomes)

  Chauhan, K., Rein, J., Rein, J. & Coca, S.

  6/11/24

  1 item of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.56) plunges 13% on low volume; -23c [12.8%]

  Coca, S.

  4/11/24

  1 item of Media coverage

  Press/Media

• ProKidney Class A dips 2% in past year

  Coca, S.

  4/11/24

  2 items of Media coverage

  Press/Media

• Weekly: ProKidney Class A (PROK: $1.55) tumbles 11% on low volume; -20c [11.4%]

  Coca, S.

  2/11/24

  1 item of Media coverage

  Press/Media

• Monthly: ProKidney Class A (PROK: $1.60) falls a second month, trailing 73% of stocks

  Coca, S.

  1/11/24

  1 item of Media coverage

  Press/Media